Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.

MLA

Asor, Roi, et al. “Oligomerization-Driven Avidity Correlates with SARS-CoV-2 Cellular Binding and Inhibition.” Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 40, Oct. 2024, p. e2403260121. EBSCOhost, https://doi.org/10.1073/pnas.2403260121.

APA

Asor, R., Olerinyova, A., Burnap, S. A., Kushwah, M. S., Soltermann, F., Rudden, L. S. P., Hensen, M., Vasiljevic, S., Brun, J., Hill, M., Chang, L., Dejnirattisai, W., Supasa, P., Mongkolsapaya, J., Zhou, D., Stuart, D. I., Screaton, G. R., Degiacomi, M. T., Zitzmann, N., … Kukura, P. (2024). Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition. Proceedings of the National Academy of Sciences of the United States of America, 121(40), e2403260121. https://doi.org/10.1073/pnas.2403260121

Chicago

Asor, Roi, Anna Olerinyova, Sean A Burnap, Manish S Kushwah, Fabian Soltermann, Lucas S P Rudden, Mario Hensen, et al. 2024. “Oligomerization-Driven Avidity Correlates with SARS-CoV-2 Cellular Binding and Inhibition.” Proceedings of the National Academy of Sciences of the United States of America 121 (40): e2403260121. doi:10.1073/pnas.2403260121.